Kotak Healthcare Growth Direct Plan
SIP amount
Min. ₹100
Lumpsum amount
Min. ₹100

Kotak Healthcare Growth Direct Plan

NAV
₹11.3990
-0.68%
(24 May)
AUM
291 Cr
TER
0.72%
Risk
Very High Risk
Insights
Asset Under Management (AUM) is in the bottom 25% of comparable funds
In beta. Send feedback here.
Compare with other fund
1Y
+110.2%
+110.0%
+104.2%
+88.5%
NA
3Y
+41.8%
+42.6%
+43.7%
+40.2%
NA
5Y
+26.5%
+31.8%
NA
+28.7%
NA
ALL
+13.6%
+19.4%
+35.5%
+17.5%
+14.0%
VOL
19.9%
19.0%
21.8%
19.0%
12.0%
TER
0.9%
0.9%
0.5%
1.2%
0.7%
AUM
₹2,352 Cr
₹957 Cr
₹4,115 Cr
₹5,043 Cr
₹291 Cr
INFO
0.68
1.02
1.63
0.92
1.17
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
Kotak Healthcare (G)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 30th Apr
Top holdings
Sun Pharmaceuticals Industries Ltd
15.7%
Cipla Ltd
7.4%
Dr Reddy's Laboratories Ltd
6.6%
Zydus Lifesciences Ltd
5.9%
Max Healthcare Institute Ltd Ordinary Shares
5.1%
Divi's Laboratories Ltd
5.0%
Alkem Laboratories Ltd
4.7%
Torrent Pharmaceuticals Ltd
4.2%
Mankind Pharma Ltd
3.7%
J.B. Chemicals & Pharmaceuticals Ltd
3.3%
Top industry exposure
Healthcare
95.1%
Financial Services
2.2%
Other information
Minimum SIP
₹100
Minimum lumpsum
₹100
Additional lumpsum
₹100
Portfolio turnover
6%
Lock-in period
-
Exit load
• 1% for redemption within 30 days
Fund objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved .
Fund manager(s)
Abhishek Bisen
Arjun Khanna
Shibani Kurian

FAQs